The effect of Del-1 by in vivo gene therapy
| Project/Area Number |
22792019
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Surgical dentistry
|
|---|
| Research Institution | Nihon University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2010 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2011: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2010: ¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
|
|---|
| Keywords | 癌 / 遺伝子 / 蛋白質 / バイオテクノロジー |
|---|
| Research Abstract |
A nude mouse was injected an oral squamous cell carcinoma cell line : SCCKN at the subcutaneously back and made a transplant tumor. The transplant tumor was treated by the gene therapy of pFasL or pFasL/E3D1 gene. The pFasL or pFasL/E3D1 gene was injected every week. The all mice of control group and/or treated of pFasL gene group were dead of 49^<th> days. But, the survival rate of mice with treated by pFasL/E3D1 was 87% at 49^<th> days. It was confirmed that the dosage of pFasL/E3D1 controls the increase of tumor, and there is a survival benefit in a transplant tumor.
|
Report
(3 results)
Research Products
(3 results)
